Global Shanghai Office represented Boehringer Ingelheim, a worldwide leading multinational pharmaceutical company, in its strategic partnering project with Shanghai ZhangJiang Biopharmaceutical Base through the whole negotiation and documentation process. As the first biopharmaceutical base established by a multinational pharmaceutical enterprise in China carrying on its production by mammalian cell culture technique, this project will establish a biopharmaceutical base in compliance with Current Good Manufacture Practices, to provide a full range of services from research and development to clinical trial for both domestic and multinational clients in biopharmaceutical industry. The groundbreaking ceremony of this project was held at ZhangJiang, Shanghai on Jun.6, 2013. Alan Zhou, the partner of Global, and Lin Zhang, an associate of Global, have been invited to attend the ceremony.  

A team of lawyers from Global Shanghai Office, led by partner Alan Zhou, has assisted Boehringer Ingelheim in the negotiation, documentation, as well as communications with the government authorities throughout the whole process of this project.